FLUARIX QUADRIVALENT
- Product NDC
- 58160-890
- Requested package NDC
- 58160-890-52
- 11-digit product format
- 581600890
- Labeler code
- 58160
- Product ID
- 58160-890_c53d4a8d-2af8-4c04-ab36-9206bc03dce4
- Type
- VACCINE
- Nonproprietary name
- influenza virus vaccine
- Dosage form
- SUSPENSION
- Route
- INTRAMUSCULAR
- Labeler
- GlaxoSmithKline Biologicals SA
- Application
- BLA125127
- Marketing category
- BLA
- Marketing start
- 2022-07-01
- Marketing end
- 0000-00-00
- Substance
- INFLUENZA A VIRUS A/DARWIN/6/2021 IVR-227 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)
- Active strength
- 15 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Purple Book Biologic Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 125127 | Fluarix, Fluarix Quadrivalent | Influenza Vaccine | 351(a) | Rx | 2026-06-01 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 58160-890-52 | 58160089052 | 10 SYRINGE in 1 CARTON (58160-890-52) > .5 mL in 1 SYRINGE (58160-890-41) | 10 syringe | 2022-07-01 | 0000-00-00 | No | No | Current |